Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER‐2/neu gene amplification in breast cancer fine‐needle samples
暂无分享,去创建一个
J. Klijanienko | A. El‐Naggar | P. Vielh | J. Couturier | Z. Maciorowski | V. Mosseri | A K El-Naggar | J Klijanienko | V Mosseri | J Couturier | M. Galut | E. Padoy | P Vielh | Z Maciorowski | M Galut | E Padoy | A. El-Naggar
[1] H. Magdelenat,et al. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis. , 1992, American journal of clinical pathology.
[2] P. Nederlof,et al. Quantification of fluorescence in situ hybridization signals by image cytometry. , 1992, Cytometry.
[3] S. Wolman. Applications of fluorescence in situ hybridization techniques in cytopathology , 1997, Cancer.
[4] A. Zajdela,et al. Cytological diagnosis by fine needle sampling without aspiration , 1987, Cancer.
[5] D. Pinkel,et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Bullerdiek,et al. Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer. , 1996, Acta cytologica.
[7] P. Terrier,et al. Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values. , 1998, European journal of cancer.
[8] P. Ravdin. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer , 1999 .
[9] S. Bull,et al. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Philippe Vielh,et al. Signal Amplification of FISH for Automated Detection Using Image Cytometry , 1997, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.
[11] B. Gusterson,et al. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] B. Brandt,et al. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients. , 1998, Biochemical and biophysical research communications.
[13] T. Sauer,et al. Ploidy analysis by in situ hybridization of interphase cell nuclei in fine‐needle aspirates from breast carcinomas: Correlation with cytologic grading , 1997, Diagnostic cytopathology.
[14] F. Révillion,et al. ERBB2 oncogene in human breast cancer and its clinical significance. , 1998, European journal of cancer.
[15] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[16] S Toikkanen,et al. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D. Slamon,et al. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. , 1996, Oncogene.
[18] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[19] I. Buño,et al. Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. , 1996, Cancer genetics and cytogenetics.
[20] T. Hudson,et al. Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. , 1995, The American journal of pathology.
[21] V. Canzonieri,et al. Defining prognostic factors in malignancies through image analysis. , 1998, European journal of cancer.
[22] T. Sauer,et al. In situ hybridization of chromosome 6 on fine‐needle aspirates from breast carcinomas: Comparison of numerical abnormalities and ER/PgR status and staining pattern , 1997, Diagnostic cytopathology.
[23] Persons Dl,et al. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization , 1997 .
[24] F. Waldman,et al. Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. , 1996, Acta cytologica.